Silver Spur TX (https://silverspurtx.com), co-founded by Dr. Eunji Chung and Dr. Yi Huang, develops nanotherapeutics for kidney and cardiovascular diseases. Our pipeline features nanotherapeutics that enable disease targeting by small molecule drugs and short RNA therapeutics, offering enhanced therapeutic outcomes with a high safety profile.